OR WAIT null SECS
June 09, 2021
Pandemic-reinforced principles of successful drug launch.
In today’s fragmented commercial environment, navigating a more complex set of challenges while adapting new approaches to product launch is critical for biopharma brand teams.
June 08, 2021
Coordination of KOL engagement is all but impossible if the information an organization collects about them is fragmented. What is needed is a centralized database that captures all information about an expert from the multiple touch points across functions and geographies.
May 10, 2021
How far should your digital strategy reach? Daniel King and Simon Davies offer five signs that indicate you need better digital support.
May 07, 2021
Now regulatory review teams have found a way to accelerate their processes — processes not particularly suited to speed — without compromising quality, accuracy, or adherence to regulations, how can this pace be maintained as we emerge from the pandemic?
May 06, 2021
Storytelling can be used very effectively to communicate with medical professionals without compromising the science, writes Stacey Rivkin.
April 20, 2021
COVID-19 has been game-changing for pharma sales, driving demand for new models and reps with the right competencies and skills to succeed in a hybrid sales environment.
Evolving preferences of HCPs during the pandemic have put an emphasis on learning new skillsets for pharma reps.
April 13, 2021
at some point, we won’t be seeing wall-to-wall COVID coverage anymore, but stories about the fallout. How can pharmaceutical brands prepare for what’s next?
April 08, 2021
Audio platforms provide new opportunities for pharma.
